A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease.
about
Strategies to promote adherence to nutritional advice in patients with chronic kidney disease: a narrative review and commentaryNonadherence to Medication Therapy in Haemodialysis Patients: A Systematic ReviewHyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherencePhosphate control in end-stage renal disease: barriers and opportunitiesLanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherenceDeterminants of compliance behaviours among patients undergoing hemodialysis in MalaysiaDeterminants of patient adherence: a review of systematic reviews.Understanding barriers to optimal medication management for those requiring long-term dialysis: rationale and design for an observational study, and a quantitative description of study variables and data.Medication adherence perspectives in haemodialysis patients: a qualitative study.Pharmacotherapy of end-stage renal disease.New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication managementA Modified Version of the Greek Simplified Medication Adherence Questionnaire for Hemodialysis Patients.The NKF-NUS hemodialysis trial protocol - a randomized controlled trial to determine the effectiveness of a self management intervention for hemodialysis patientsAnalysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients.Impact of prescription benefit coverage limits on sevelamer hydrochloride adherence for patients with ESRD.A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patientsMapping the knowledge structure of research on patient adherence: knowledge domain visualization based co-word analysis and social network analysisAssociation between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients.Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis.Summary adherence estimates do not portray the true incongruity between drug intake, nurse documentation and physicians' ordersTargets for parathyroid hormone in secondary hyperparathyroidism: is a "one-size-fits-all" approach appropriate? A prospective incident cohort studyCalcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients.Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysisAn experience of vascular access for hemodialysis in Brazil.Improving outcomes in patients with coexisting multimorbid conditions-the development and evaluation of the combined diabetes and renal control trial (C-DIRECT): study protocol.The Relationship between Cognitive Appraisal and Adherence to Medical Regimens in Type 2 Diabetic Patients.Non-adherence in patients on peritoneal dialysis: a systematic review.Medication burden in CKD-5D: impact of dialysis modality and setting.Management of hyperphosphataemia in chronic kidney disease-challenges and solutionsSources of drug coverage among Medicare beneficiaries with ESRD.Rates of Intentional and Unintentional Nonadherence to Peritoneal Dialysis Regimes and Associated FactorsSelf-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease.Racial/ethnic differences in illness, perceptions in minority patients undergoing maintenance hemodialysisHelp needed in medication self-management for people with visual impairment: case-control study.Novel Therapeutic Options for the Treatment of Mineral Metabolism Abnormalities in End Stage Renal Disease.Medication adherence in randomized controlled trials evaluating cardiovascular or mortality outcomes in dialysis patients: A systematic reviewThe adequacy of phosphorus binder prescriptions among American hemodialysis patients.Geriatric syndromes are potential determinants of the medication adherence status in prevalent dialysis patients.Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patientsLanthanum carbonate oral powder: satisfaction, preference and adherence in French and Spanish patients with end-stage renal disease.
P2860
Q26764804-712899B8-044A-40DD-8A52-96CB6038BEFFQ26774337-B3D7C461-81B5-49BE-898E-FE243CBBCA8EQ26830013-4D0488AC-FC17-4156-BFFD-86272253FFC7Q26853372-768B0E6C-7C01-4274-861A-E4E739CC2347Q27013882-8DBF0472-C77D-4CCF-822B-8E67B26A367BQ28482035-7BCEC767-5FF3-4CD7-BFBC-469829BE831AQ30541800-B4D1B851-DA4C-49FF-B82D-058C6D079056Q30657472-98332131-65F5-4AD6-83B6-D1D3663408BBQ30852621-36111048-757E-4119-8941-83F1794D3118Q33531889-99069832-1C35-4EA6-88D0-08C6AC49D3DFQ33577423-63747EEF-F0C2-4172-A5BE-4D21A40EF844Q33750618-A4F21DF1-7488-424F-9CB1-256013307F9AQ33805621-BFE15E32-07BA-4AC9-991C-BCAF9B6A5522Q33890218-D71D9C4B-948A-4085-B4DD-F2517786DB26Q33931931-1F1C8A5F-F663-4F38-ABCD-3DCE8A5B91F8Q34116591-D494774F-0822-402F-99AA-B39F692F8FA6Q34230166-D233CA49-EE87-4FCC-8CD4-103553D93147Q34234631-4244FB6A-AEF3-4950-9EAF-196366AE10FDQ34406863-60240BDE-AA36-4147-927E-C72307702D89Q34503699-FBC4C30C-16F9-401C-96F5-347FF4B039FCQ34538433-BA97FDAC-5534-425C-B729-A360BA09CDA6Q34547461-D42AC370-BC61-473C-8051-66AF7FD9089EQ35007369-B7C33001-125F-4411-93F1-251478CF28BEQ35052703-ED37E9B0-397A-4730-93C3-2A1F7075965FQ35088873-D939811F-37B4-46F6-BA17-9BBC8CBA97B7Q35100501-45867202-DA6E-4601-9283-F8366A61D852Q35106539-D7073C48-8988-4C7E-917F-0E29657268FDQ35310494-91CFDE42-F239-4EC4-A0D6-2B442AD6126AQ35608435-2E88BB67-967A-4103-86E5-26376868CA07Q35917495-3504CAFF-4550-47B5-A2AD-AAA48F892E02Q35937345-C4685CBD-73C2-4C77-829F-D131A7C5070DQ35988756-1396560E-1842-4DDD-96C1-57EBE5DCF188Q36077864-6FA3DC1D-F87A-4787-97AF-595300532303Q36113864-ED519EDB-7C83-4779-94FF-E01E19563C66Q36225208-B84969C5-45D1-4C1E-9A7C-6D93BA7B29B5Q36265484-FDF06AE2-3BB2-47BA-8BBF-AF82240E06EDQ36716948-DEC92A6C-A8AA-4761-9268-F341F9D38878Q37015932-D8DCAC9D-94C8-42C5-8EBE-E241F866BC84Q37211036-0ACCAB7B-8AE4-425A-9529-A29DAEEBE467Q37368351-9FD64E78-4249-4788-8443-F7116E043029
P2860
A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A systematic review of the pre ...... with end-stage renal disease.
@ast
A systematic review of the pre ...... with end-stage renal disease.
@en
A systematic review of the pre ...... with end-stage renal disease.
@nl
type
label
A systematic review of the pre ...... with end-stage renal disease.
@ast
A systematic review of the pre ...... with end-stage renal disease.
@en
A systematic review of the pre ...... with end-stage renal disease.
@nl
prefLabel
A systematic review of the pre ...... with end-stage renal disease.
@ast
A systematic review of the pre ...... with end-stage renal disease.
@en
A systematic review of the pre ...... with end-stage renal disease.
@nl
P2093
P2860
P921
P356
P1433
P1476
A systematic review of the pre ...... with end-stage renal disease.
@en
P2093
Christina Karamanidou
Jane Clatworthy
John Weinman
P2860
P2888
P356
10.1186/1471-2369-9-2
P5008
P577
2008-01-31T00:00:00Z
P5875
P6179
1001943039